童颜针"价格战"正迎来最激烈的时刻。 9月23日，新氧（SY.O）正式推出奇迹童颜3.0，定价为2999元，创下童颜针史上最低价——目前市面上 的艾维岚、塑妍萃等童颜针单价基本在1.3万元到2.4万元不等。 操作方面，新氧的奇迹童颜3.0主要采取童颜针"塑缇妍"复配玻尿酸的形式。 塑缇妍的出品方是江苏西宏生物医药有限公司（下称"西宏生物"），其母公司系正在冲刺港股IPO的东 方妍美（成都）生物技术股份有限公司。 据金星透露，1.0、2.0版本分别采用的是普丽妍（南京）医疗科技有限公司（下称"普丽妍"）的普丽 妍、长春圣博玛生物材料有限公司（下称"圣博玛"）的艾维岚，这两家厂商要求终端售价分别为16800 元/支，18800元/支，但新氧的定价分别低至4999元、5999元。 这引发了上游医美材料商的不满，普丽妍、圣博玛都先后向新氧发函，要求下架童颜针的产品。 今年7月，西宏生物的童颜针（丽真然）获批上市，其大中华区的推广、商业化等权益被授权给了康哲 药业（0867.HK）。 "塑缇妍是我们与西宏生物定制的产品，与丽真然为同款童颜针，但型号略有不同。"新氧CEO金星告诉 信风，"西宏生物不干涉下游的定价。" 短 ...

信风自接近京东健康人士处获悉，位于北京国贸商圈万通中心一层的京东自营医美门店（下称"国贸店"）将在10月中旬正式对外营业。 这是继此前京东医美旗下首家自营门店在北京市亦庄开业后的第二家自营门店（亦庄店）。 据信风了解，国贸店是京东医美旗下首家独立门店，面积等规模都超过亦庄店。 尽管国贸店尚未开张，但京东医美已为此做了充分的准备。 京东医美在京东APP和京东医美微信小程序对自营门店上线了"300元无门槛开业礼券"的活动。 在300元无门槛礼券的活动下，京东医美不少产品的价格都十分"扛打"。例如嗨体2.5的的礼券价仅为99元，市面价格则基本在500元以上。 如此举措吸引了不少用户的参与。9月11日上线后的短短3天，用户共领券近1800张，预售成交额突破100万元，预计仍将快速增长。 另据接近京东健康人士处透露，京东医美（国贸店）正式营业第一周的服务名额已接近约满。 后续京东医美是否会有更多门店的开张，正受到期待。 京东医美门店展业迎来新进展。 风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状 ...

Core Viewpoint - JD's self-operated medical beauty clinics are making significant progress in channel expansion, particularly through collaboration with Meituan, marking a strategic move in the medical beauty sector [1][4]. Group 1: JD's Medical Beauty Clinic Launch - JD's self-operated medical beauty clinic, named "JD Self-operated Dermatology (Yizhuang Store)," has launched on the Meituan app [2][3]. - This collaboration with Meituan represents the first partnership between JD and Meituan in the medical beauty field [4]. - The Yizhuang Store has received subsidies from Meituan, resulting in some product packages being priced lower on Meituan than on JD's own app [5][14]. Group 2: Pricing and Competition - The pricing strategy shows that even a major player like JD relies on Meituan's local market dominance for customer acquisition [6]. - For example, the "Skin Rejuvenation Package" is priced at 948 yuan on Meituan compared to 998 yuan on JD [15]. - Despite JD's brand advantage, the Yizhuang Store's sales on Meituan are currently limited, with only 5 units sold for the "Bubble Needle" package [16]. Group 3: Future Plans and Expansion - JD plans to open a second self-operated clinic in Beijing's Guomao area by September 30 [20]. - There is anticipation regarding whether more JD medical beauty clinics will be integrated into Meituan in the future [21]. Group 4: Multi-Channel Strategy - JD is also integrating various medical beauty institutions into its app, continuing its dual strategy of being both a platform and a self-operated entity [23][24]. - This approach contrasts with Meituan's focus on being a traffic entry point for offline institutions [25]. Group 5: Industry Context - JD is not the first internet platform to enter the medical beauty sector; New Oxygen has already established 30 self-operated clinics across nine cities since May 2023 [26]. - New Oxygen's clinics also participate in Meituan's subsidy programs, indicating a trend where major players leverage Meituan for customer acquisition [30][31].

Core Viewpoint - The article discusses a case of illegal medical advertising in the cosmetic surgery industry, highlighting the importance of regulatory compliance for medical beauty institutions and the potential penalties for violations [1][2][3] Group 1: Case Details - A medical beauty shop was found to have published 11 promotional videos on Douyin without obtaining the necessary medical advertising review approval, despite spending 1,000 yuan on the advertising campaign [1] - The promotional content included various cosmetic procedures and their prices, such as 199 yuan for water light injections and 499 yuan for doll injections [1] Group 2: Regulatory Actions - The local market supervision bureau stated that the shop violated the Advertising Law of the People's Republic of China, which prohibits the publication of advertisements without prior review [2] - The shop was subject to administrative penalties, including a fine that could range from one to three times the advertising cost, or a fixed penalty of 100,000 to 200,000 yuan for low advertising costs [2] Group 3: Industry Implications - The market supervision bureau emphasized the need for medical beauty institutions to comply with advertising regulations to protect consumer health and safety, warning against exaggerated claims and misleading marketing tactics [3] - The bureau plans to increase enforcement efforts to combat false advertising and illegal promotions in the medical beauty sector, aiming to safeguard consumer rights [3]